DOCSLIB.ORG

Hemodynamics Overview and Terminology

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Hemodynamics Overview and Terminology Hemodynamics Hemodynamics Bioengineering 6000 CV Physiology Overview and Terminology • Parameters – Pressure – Velocity Arterioles – Flow • laminar vs. turbulent – Resistance – Viscosity – Energy – Area – Volume Hemodynamics Bioengineering 6000 CV Physiology Structural Overview Intro to Circulation Bioengineering 6000 CV Physiology Functional Overview Arterial System Bioengineering 6000 CV Physiology Blood Distribution • Velocities/Flows Percent of blood Cross-sectional area volume – Aorta: 30-50 cm/s – Capillaries: 0-1 cm/s Velocity or 5.5 hours/mm3 • Blood mass: 8% of Pressure body mass • Volumes (percent of total blood volume) – Systemic: 83% • Arteries: 11% • Capillaries: 5% Aorta Arteries Arterioles Capillaries Venules Veins Venae • Veins: 67% Cava – Pulmonary: 12% Pressure Velocity – Heart: 5% Cross-sectional area Percent of blood volume Hemodynamics Bioengineering 6000 CV Physiology Velocity vs. Area • Flow is constant throughout • Flow =∫velocity * area Hemodynamics Bioengineering 6000 CV Physiology Hemodynamics Basics • "The problem of treating the pulsatile flow of blood through the cardiovascular system in precise mathematical terms is insuperable" (Berne and Levy) – Blood is not Newtonian (viscosity is not constant) – Flow is not steady but pulsatile – Vessels are elastic, multibranched conduits of constantly changing diameter and shape. – Use equations qualitatively • Local control of blood flow Hemodynamics Bioengineering 6000 CV Physiology Laminar Flow and Turbulence • Laminar flow – Parabolic profile • Pulsatile laminar flow – Velocity changes – May reverse direction • Turbulent flow – Nonaligned movement – Noisy (BP cuff) Velocity Profiles Velocity – Reynolds number • > 1000 = turbulence • > 200 = eddies possible – Rarely occurs in healthy vessels Hemodynamics Bioengineering 6000 CV Physiology Hemodynamic Parameters . P = pressure V = volume Q = flow η = viscosity ∆P • Resistance R = ∆Q˙ ∆V • Compliance C = ∆P ∆P • Inertance L = ∆Q/˙ ∆t ⇡r4 • Poiseuille's Law Q˙ =(P1 P2) – laminar flow − 8⌘l – Newtonian fluid V – rigid tube 8⌘l (I = ) – works for small R = R arteries and ⇡r4 veins Hemodynamics Bioengineering 6000 CV Physiology Hemodynamic Parameters . P = pressure V = volume Q = flow η = viscosity ∆P • Resistance R = ∆Q˙ ∆V • Compliance C = ∆P ∆P • Inductance L = ∆Q/˙ ∆t ⇡r4 • Poiseuille's Law Q˙ =(P1 P2) – laminar flow − 8⌘l – Newtonian fluid V – rigid tube 8⌘l (I = ) – works for small R = R arteries and ⇡r4 veins Hemodynamics Bioengineering 6000 CV Physiology Resistance and Compliance ∆P R = ˙ • Veins vs. arteries ∆Q – have 24 times the Normal compliance of arteries – carry 65% of the blood Blood Flow – have even higher blood 0 100 200 storage capacity Arterial Pressure [mm Hg] • Autonomic control Sympathetic inhibition Sympathetic stimulation – alters resistance but not compliance (slopes of ∆V C = curves) Venous ∆P – acts to shift blood volume Blood Volume Arterial 0 70 140 Pressure [mm Hg] Hemodynamics Bioengineering 6000 CV Physiology Viscosity U F A • Viscosity increases with u y Y – increased hematocrit – constrictions in vessels • Viscosity decreases with ⌧ F/A Shear stress – increased flow velocity ⌘ = = = du/dy U/Y Shear rate – vessel diameter below 300 µm Definition for 10 homogenous Newtonian fluid 8 Poor formula for viscosity in 6 small vessels Blood 4 2 Plasma Viscosity (water=1) Viscosity Water 10 20 30 40 50 60 70 Hematocrit [%] Hemodynamics Bioengineering 6000 CV Physiology Viscosity Hemodynamics Bioengineering 6000 CV Physiology Viscosity Shear Thinning or Thickening? Hemodynamics Bioengineering 6000 CV Physiology Factors that Affect Viscosity • Flow rate: as flow decreases, viscosity increases up to 10-fold. Mechanism: RBCs adhering to each other, and the vessel walls. • RBCs stick at constrictions, increase viscosity. • Concentration, distribution, shape, and rigidity of the suspended particles (e.g., RBCs drift to the center so velocity profile flattens from ideal parabolic) • Fahraeus-Lindqvist effect: reduced η when RBCs line up in small vessels (< 300 µm). • In very small vessels (< 20 µm), η increases as RBCs fill the capillaries, “tractor tread” motion • Temperature, blood pressure, presence of anticoagulants, • Measurement conditions: higher in vitro than in vivo. • History (pulsatile flow) Hemodynamics Bioengineering 6000 CV Physiology Velocity and Pressure • Example: Aortic stenosis – increased velocity ˙ ˙ ˙ ˙ ˙ ˙ – decreased lateral Q = Qo Q = Qo Q = Qo pressure v = vo v = kvo v = vo – reduced coronary Ptot = Po Ptot = Po Ptot = Po flow = Pdo + Plo = Pd + Pl – coronary ischemia 1 2 1 2 Pd = ⇢v P = ⇢(kv ) P = P 2 o d 2 o d do 2 = Pdo = k Pdo Pl = Plo P = P P Pl = Plo l tot − d <Plo Hemodynamics Bioengineering 6000 CV Physiology Aortic Stenosis • Pressure losses P (lower than – kinetic energy ao conversion normal) – energy loss (friction) Pavo Coronary Coronary artery artery Pv Left ventricle Hemodynamics Bioengineering 6000 CV Physiology Resistance of the Circulatory System • Resistance high where Cross-sectional area pressure drops Velocity • Arterioles have highest resistance • Paradox? Pressure – arterioles have more total area than arteries – vessels with larger area have smaller resistance – but arterioles have larger resistance than arteries? Aorta Arteries Arterioles Capillaries Venules Veins Venae Cava Velocity Cross-sectional area Pressure Percent of blood volume Hemodynamics Bioengineering 6000 CV Physiology Resistance-Area Paradox An,rn,Rn Aw =4An Aw,rw,Rw rw =2rn Rt • Net flow must be 1 4 1 4 constant = = R R R • One vessel 8⌘l k t 1=1 n n R = = X splitting to four ⇡r4 r4 R k increases total n Rt = = 4 resistance! 4 4rn k k k 1 k Rt Rw = 4 = 4 = 4 = 4 = rw (2rn) 16rn 4 ⇤ 4rn 4 Rt =4Rw! Hemodynamics Bioengineering 6000 CV Physiology Resistance Break Even Point • Break-even point at 16 to 1 (for Rw=Rt). • Capillaries have more than 16:1 ratio An,rn,Rn Aw,rw,Rw Rt At = 16An =4Aw Rw = Rt Hemodynamics Bioengineering 6000 CV Physiology.
Load more

Recommended publications
  • Radionuclear Measurement of Peripheral Hemodynamics In
    RadionuclearMeasurementof Peripheral Hemodynamics in Selection of Vasodilators for Treatment of Heart Failure Yasuhiro Todo, Mitsumasa Ohyanagi, Ryu Fujisue, and Tadaaki Iwasaki Hyogo College ofMedicine, Nishinomiya, Japan Inorder to select the optimal vasodilator for the treatment of patients with congestive heart failure (CHF), the acute effects of three vasodilators (isosorbide dinitrate (ISDN) 5 mg, nifedipine 10 mg, and prazosin 1 mg) on peripheral capacitance and resistance vessels (CV and RV)were evaluated by a newly devised radionuclear technique (Study 1).Thirty-six @ patients with chronic CHF were dividedinto Group A (ejectionfraction (EF) 35%, n = 20, mean EF: 47.2 ±6.5%) and B (EF < 35%, n = 16, mean EF: 24.8 ±7.1%). ISDNproduced the strongest CVdilatation(25% in both groups). Nifedipinereduced RVtone in Groups A and B (14% and 27%, respectively),and CVtone in Group A (6%). Prazosin had the most prominent effects on both vessels in Group B. From these results, it appeared: (a) ISDN is indicated for the cases with increased CV tone, (b) nifedipine is suitable for those with @ increased RV tone, (C)in cases of increased tone in both vessels, nifedipine (when EF 35%) or prazosin (when EF < 35%) is optimal.To evaluate the validityof this assignment, 49 subjects with CHF were divided into Group 1 (n = 16, increased CV tone), Group 2 (n = 17, increased RV tone), and Group 3 (n = 16, increased CV and RV tone) in Study 2. In Group 1, the changes of all indexes were not significantly different between the subjects treated with optimal drug based on the assignment (subgroup P) and those with a non-optimaldrug (subgroup N)after 2 wk of therapy.
    [Show full text]
  • Relationship Between Vasodilatation and Cerebral Blood Flow Increase in Impaired Hemodynamics: a PET Study with the Acetazolamide Test in Cerebrovascular Disease
    CLINICAL INVESTIGATIONS Relationship Between Vasodilatation and Cerebral Blood Flow Increase in Impaired Hemodynamics: A PET Study with the Acetazolamide Test in Cerebrovascular Disease Hidehiko Okazawa, MD, PhD1,2; Hiroshi Yamauchi, MD, PhD1; Hiroshi Toyoda, MD, PhD1,2; Kanji Sugimoto, MS1; Yasuhisa Fujibayashi, PhD2; and Yoshiharu Yonekura, MD, PhD2 1PET Unit, Research Institute, Shiga Medical Center, Moriyama, Japan; and 2Biomedical Imaging Research Center, Fukui Medical University, Fukui, Japan Key Words: acetazolamide; cerebrovascular disease; cerebral The changes in cerebral blood flow (CBF) and arterial-to- blood volume; vasodilatory capacity; cerebral perfusion pressure capillary blood volume (V0) induced by acetazolamide (ACZ) are expected to be parallel each other in the normal circula- J Nucl Med 2003; 44:1875–1883 tion; however, it has not been proven that the same changes in those parameters are observed in patients with cerebro- vascular disease. To investigate the relationship between changes in CBF, vasodilatory capacity, and other hemody- namic parameters, the ACZ test was performed after an The ability of autoregulation to maintain the cerebral 15O-gas PET study. Methods: Twenty-two patients with uni- blood flow (CBF), which resides in the cerebral circulation lateral major cerebral arterial occlusive disease underwent despite transient changes in systemic mean arterial blood 15 PET scans using the H2 O bolus method with the ACZ test pressure, has been shown to occur via the mechanism of 15 after the O-gas steady-state method. CBF and V0 for each arteriolar vasodilatation in the cerebral circulation (1). The subject were calculated using the 3-weighted integral vasodilatory change in the cerebral arteries is assumed for method as well as the nonlinear least-squares fitting method.
    [Show full text]
  • Hemodynamic Effects of Vasodilators and Long-Term Response in Heart Failure
    JACC Vol. 3, No.6 1521 June 1984:1521-30 REPORTS ON THERAPY Hemodynamic Effects of Vasodilators and Long-Term Response in Heart Failure JOSEPH A. FRANCIOSA, MD, FACC, W. BRUCE DUNKMAN, MD, FACC,* CHERYL L. LEDDY, MD* Philadelphia, Pennsylvania and Little Rock, Arkansas Hemodynamic responses to vasodilators are commonly ml/min per kg (p < 0.01), and exercise duration also assessed when starting long-term vasodilator treatment increased by 1.8 ± 3.5 minutes (p < 0.01). Changes in in patients with chronic left ventricular failure, although maximal oxygen uptake, however, did not correlate with the relation between short- and long-term responses is short-term changes in pulmonary wedge pressure (cor• not established. Thus, short- and long-term hemody• relation coefficient [r] = - 0.14), cardiac index (r = namic responses to placebo and vasodilators (isosorbide - 0.01) or systemic vascular resistance (r = - 0.20). dinitrate, minoxidil and enalapril or captopril) were Long-term hemodynamic changes also failed to correlate measured and long-term clinical efficacy was assessed with changes in exercise capacity. Baseline hemody• by changes in exercise capacity after 1 to 5 months of namics, cardiac dimensions and left ventricular ejection vasodilator administration (plus digitalis and diuretic fraction before vasodilator administration all failed to agents) in 46 patients with New York Heart Association correlate with baseline exercise capacity or with long• fun~tional class II to IV heart failure caused by cardio• term changes in exercise capacity. myopathy. There were no significant changes in hemo• Thus, hemodynamic measurements at initiation or dynamics or exercise capacity during placebo treatment.
    [Show full text]
  • Medical Management of Advanced Heart Failure
    CLINICAL CARDIOLOGY CLINICIAN’S CORNER Medical Management of Advanced Heart Failure Anju Nohria, MD Context Advanced heart failure, defined as persistence of limiting symptoms de- Eldrin Lewis, MD spite therapy with agents of proven efficacy, accounts for the majority of morbidity and mortality in heart failure. Lynne Warner Stevenson, MD Objective To review current medical therapy for advanced heart failure. EART FAILURE HAS EMERGED AS Data Sources We searched MEDLINE for all articles containing the term advanced a major health challenge, in- heart failure that were published between 1980 and 2001; EMBASE was searched from creasing in prevalence as age- 1987-1999, Best Evidence from 1991-1998, and Evidence-Based Medicine from 1995- adjusted rates of myocardial 1999. The Cochrane Library also was searched for critical reviews and meta-analyses Hinfarction and stroke decline.1 Affect- of congestive heart failure. ing 4 to 5 million people in the United Study Selection Randomized controlled trials of therapy for 150 patients or more States with more than 2 million hospi- were included if advanced heart failure was represented. Other common clinical situ- talizations each year, heart failure alone ations were addressed from smaller trials as available, trials of milder heart failure, con- accounts for 2% to 3% of the national sensus guidelines, and both published and personal clinical experience. health care budget. Developments her- Data Extraction Data quality was determined by publication in peer-reviewed lit- alded in the news media increase pub- erature or inclusion in professional society guidelines. lic expectations but focus on decreas- Data Synthesis A primary focus for care of advanced heart failure is ongoing iden- ing disease progression in mild to tification and treatment of the elevated filling pressures that cause disabling symp- moderate stages2,3 or supporting the cir- toms.
    [Show full text]
  • Chapter 9 Monitoring of the Heart and Vascular System
    Chapter 9 Monitoring of the Heart and Vascular System David L. Reich, MD • Alexander J. Mittnacht, MD • Martin J. London, MD • Joel A. Kaplan, MD Hemodynamic Monitoring Cardiac Output Monitoring Arterial Pressure Monitoring Indicator Dilution Arterial Cannulation Sites Analysis and Interpretation Indications of Hemodynamic Data Insertion Techniques Systemic and Pulmonary Vascular Resistances Central Venous Pressure Monitoring Frank-Starling Relationships Indications Monitoring Coronary Perfusion Complications Electrocardiography Pulmonary Arterial Pressure Monitoring Lead Systems Placement of the Pulmonary Artery Catheter Detection of Myocardial Ischemia Indications Intraoperative Lead Systems Complications Arrhythmia and Pacemaker Detection Pacing Catheters Mixed Venous Oxygen Saturation Catheters Summary References HEMODYNAMIC MONITORING For patients with severe cardiovascular disease and those undergoing surgery associ- ated with rapid hemodynamic changes, adequate hemodynamic monitoring should be available at all times. With the ability to measure and record almost all vital physi- ologic parameters, the development of acute hemodynamic changes may be observed and corrective action may be taken in an attempt to correct adverse hemodynamics and improve outcome. Although outcome changes are difficult to prove, it is a rea- sonable assumption that appropriate hemodynamic monitoring should reduce the incidence of major cardiovascular complications. This is based on the presumption that the data obtained from these monitors are interpreted correctly and that thera- peutic decisions are implemented in a timely fashion. Many devices are available to monitor the cardiovascular system. These devices range from those that are completely noninvasive, such as the blood pressure (BP) cuff and ECG, to those that are extremely invasive, such as the pulmonary artery (PA) catheter. To make the best use of invasive monitors, the potential benefits to be gained from the information must outweigh the potential complications.
    [Show full text]
  • Hemodynamic Parameters in the Assessment of Fluid Status in A
    PERIOPERATIVE MEDICINE ABSTRACT Background: Measuring fluid status during intraoperative hemorrhage is challenging, but detection and quantification of fluid overload is far more diffi- cult. Using a porcine model of hemorrhage and over-resuscitation, it is hypoth- Hemodynamic Parameters esized that centrally obtained hemodynamic parameters will predict volume status more accurately than peripherally obtained vital signs. in the Assessment Methods: Eight anesthetized female pigs were hemorrhaged at 30 ml/min to a blood loss of 400 ml. After each 100 ml of hemorrhage, vital signs (heart of Fluid Status in a rate, systolic blood pressure, mean arterial pressure, diastolic blood pressure, pulse pressure, pulse pressure variation) and centrally obtained hemodynamic Porcine Hemorrhage and parameters (mean pulmonary artery pressure, pulmonary capillary wedge pressure, central venous pressure, cardiac output) were obtained. Blood Resuscitation Model volume was restored, and the pigs were over-resuscitated with 2,500 ml of crystalloid, collecting parameters after each 500-ml bolus. Hemorrhage Eric S. Wise, M.D., Kyle M. Hocking, Ph.D., and resuscitation phases were analyzed separately to determine differences Monica E. Polcz, M.D., Gregory J. Beilman, M.D., among parameters over the range of volume. Conformity of parameters during Colleen M. Brophy, M.D., Jenna H. Sobey, M.D., hemorrhage or over-resuscitation was assessed. Philip J. Leisy, M.D., Roy K. Kiberenge, M.D., Bret D. Alvis, M.D. Results: During the course of hemorrhage, changes from baseline euvolemia were observed in vital signs (systolic blood pressure, diastolic blood pressure, ANESTHESIOLOGY 2021; 134:607–16 and mean arterial pressure) after 100 ml of blood loss.
    [Show full text]
  • Cerebral Hemodynamics During Cerebral Ischemia Induced by Acute Hypotension
    Cerebral Hemodynamics during Cerebral Ischemia Induced by Acute Hypotension Frank A. Finnerty Jr., … , Lloyd Witkin, Joseph F. Fazekas J Clin Invest. 1954;33(9):1227-1232. https://doi.org/10.1172/JCI102997. Research Article Find the latest version: https://jci.me/102997/pdf CEREBRAL HEMODYNAMICS DURING CEREBRAL ISCHEMIA INDUCED BY ACUTE HYPOTENSION 1 BY FRANK A. FINNERTY, JR., LLOYD WITKIN, AND JOSEPH F. FAZEKAS WITH THE TECHNICAL ASSISTANCE OF MARIE LANGBART AND WILLIAM K. YOUNG (From the Department of Medicine, Georgetown University School of Medicine and the George- town and George Washington Medical Divisions, District of Columbia General Hospital, Washington, D. C.) (Submitted for publication February 1, 1954; accepted May 20, 1954) The extreme dependence of the brain upon its seven patients with malignant hypertension. In seven circulation for substrates essential for the main- subjects, the mean arterial pressure was reduced sig- nificantly below normal but not to the extent of inducing tenance of its metabolic activity is well recognized. signs of cerebral ischemia. Five patients with spontane- A cessation of the cerebral circulation for only a ous postural hypotension were also studied. few minutes, as occurs in cardiac arrest, results in Control studies were obtained after the subject had been irreversible brain damage. The brain, for the most tilted (head up) 30 to 40 degrees for a period of at least part, is an aerobic organ and its large oxygen de- 30 minutes. The subjects in the drug-induced hypo- tension group were then given a 1 per cent solution of mands probably account for its unusual suscepti- hexamethonium 2 intravenously at a rate of 1 mg.
    [Show full text]
  • Persistent Hemodynamic Benefits of Cardiac Resynchronization
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Journal of the American College of Cardiology Vol. 53, No. 7, 2009 © 2009 by the American College of Cardiology Foundation ISSN 0735-1097/09/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2008.08.079 Cardiac Resynchronization Therapy Persistent Hemodynamic Benefits of Cardiac Resynchronization Therapy With Disease Progression in Advanced Heart Failure Wilfried Mullens, MD, Tanya Verga, RN, Richard A. Grimm, DO, FACC, Randall C. Starling, MD, MPH, FACC, Bruce L. Wilkoff, MD, FACC, W. H. Wilson Tang, MD, FACC Cleveland, Ohio Objectives Our aim was to determine the potential hemodynamic contributions of cardiac resynchronization therapy (CRT) in patients admitted for advanced decompensated heart failure. Background CRT restores synchrony of the heart resulting in hemodynamic support that can facilitate the reversal of left ven- tricular (LV) remodeling in some patients. Methods A total of 40 consecutive patients with advanced decompensated heart failure and CRT implanted Ͼ3 months, admitted due to hemodynamic derangements, underwent simultaneous comprehensive echocardiographic and invasive hemodynamic evaluation under different CRT settings. Results All patients (mean LV ejection fraction 22 Ϯ 7%, LV end-diastolic volume 323 Ϯ 140 ml, 40% ischemic) had experienced progressive cardiac remodeling despite adequate LV lead positions and continuous biventricular pacing. A significant worsening of hemodynamics was observed immediately when CRT was programmed OFF in the majority (88%) of patients (systolic blood pressure: 105 Ϯ 12 mm Hg to 98 Ϯ 13 mm Hg; pulmonary capil- lary wedge pressure: 17 Ϯ 6mmHgto21Ϯ 7 mm Hg; cardiac output: 4.6 Ϯ 1.4 l/min·m2 to 4.0 Ϯ 1.1 l/min·m2; all p Ͻ 0.001).
    [Show full text]
  • Clinical and Research Considerations
    Journal of Cardiac Failure Vol. 22 No. 8 2016 Consensus Statement Clinical and Research Considerations for Patients With Hypertensive Acute Heart Failure: A Consensus Statement from the Society of Academic Emergency Medicine and the Heart Failure Society of America Acute Heart Failure Working Group SEAN P. COLLINS, MD, MSc,1,* PHILLIP D. LEVY, MD, MPH,2 JENNIFER L. MARTINDALE, MD,3 MARK E. DUNLAP, MD,4 ALAN B. STORROW, MD,1 PETER S. PANG, MD, MSc,5 NANCY M. ALBERT, RN, PhD,6 G. MICHAEL FELKER, MD, MS,7 GREGORY J. FERMANN, MD,8 GREGG C. FONAROW, MD,9 MICHAEL M. GIVERTZ, MD,10 JUDD E. HOLLANDER, MD,11 DAVID J. LANFEAR, MD,12 DANIEL J. LENIHAN, MD,13 JOANN M. LINDENFELD, MD,13 W. FRANK PEACOCK, MD,14 DOUGLAS B. SAWYER, MD, PhD,15 JOHN R. TEERLINK, MD,16 AND JAVED BUTLER, MD, MPH, MBA17 Nashville, Tennessee; Detroit, Michigan; New York and Long Island, New York; Cleveland and Cincinnati, Ohio; Indianapolis, Indiana; Raleigh-Durham, North Carolina; Los Angeles and San Francisco, California; Boston, Massachusetts; Philadelphia, Pennsylvania; Houston, Texas; and Portland, Maine ABSTRACT Management approaches for patients in the emergency department (ED) who present with acute heart failure (AHF) have largely focused on intravenous diuretics. Yet, the primary pathophysiologic derangement un- derlying AHF in many patients is not solely volume overload. Patients with hypertensive AHF (H-AHF) represent a clinical phenotype with distinct pathophysiologic mechanisms that result in elevated ventricu- lar filling pressures. To optimize treatment response and minimize adverse events in this subgroup, we propose that clinical management be tailored to a conceptual model of disease based on these mechanisms.
    [Show full text]
  • INDE 221 Spring 2010 Syllabus Part 2
    Human Health & Disease Mondays, Tuesdays, Thursdays and Fridays 9:00 - 11:50 AM Lectures: Room M-112, Labs: Fleischmann IINNDDEE 222211 SSpprriinngg 22001100 Syllabus SSyyllllaabbuuss PPaarrtt 22 (2010) Year's Last Syllabus (2010) Year's Last Human Health & Disease Inde 221 Spring 2010 Table of Contents CARDIOVASCULAR BLOCK SYLLABUS SCHEDULE 7 SYLLABUS PREFACE 11 CARDIAC MUSCLE AND FHC 15 EXCITATION-CONTRACTION COUPLING Syllabus27 NERNST POTENTIAL AND OSMOSIS 43 EXCITABILITY AND CONDUCTION 51 CIRCULATORY VESSEL HISTOLOGY LAB 63 CARDIAC ACTION POTENTIAL 71 CONTROL OF HEART RHYTHM (2010) 85 AUTONOMIC DRUGS OVERVIEW I 97 ELECTROCARDIOGRAM (ECG) 99 LESIONS OF BLOOD VESSELS 109 THROMBOEMBOLIC DISEASE 117 CARDIAC REFLEXESYear's 123 AUTONOMIC DRUGS OVERVIEW II 141 ECG SMALL GROUPS 143 LastAUTONOMIC DRUGS: CHOLINERGICS 147 CARDIAC MUSCLE MECHANICS 149 AUTONOMIC DRUGS: ANTICHOLINERGICS 175 ARRHYTHMIAS 177 AUTONOMIC DRUGS: SYMPATHOMIMETICS I 203 VENTRICULAR PHYSIOLOGY 205 AUTONOMIC DRUGS: SYMPATHOMIMETICS II 235 STARLING CURVE AND VENOUS RETURN 237 CARDIAC OUTPUT AND CATHETERIZATION 245 AUTONOMIC DRUGS: ADRENOCEPTOR BLOCKERS 267 PHYSICS OF CIRCULATION Syllabus269 CASE DISCUSSIONS: AUTONOMIC DRUGS 289 SMOOTH MUSCLE 291 ISCHEMIC AND VALVULAR HEART DISEASE 303 RENAL CIRCULATION (2010) 323 HYPERTENSION 333 CARDIOMYOPATHY, MYOCARDITIS AND ATRIAL MYXOMA 351 ENDOTHELIUM AND CORONARY CIRCULATION 369 ANGINA PECTORIS 389 DRUGS USEDYear's IN HYPERTENSION 397 SHOCK 399 ADULT CARDIAC LAB 413 CARDIAC ANESTHESIA & BYPASS 421 LastEXERCISE PHYSIOLOGY 431 ISCHEMIC
    [Show full text]
  • Basics of Hemodynamics
    P1: RNK/... P2: RNK 9781405176255 BLUK110-Stouffer August 1, 2007 13:57 PART I Basics of hemodynamics 1 P1: RNK/... P2: RNK 9781405176255 BLUK110-Stouffer August 1, 2007 13:57 2 P1: RNK/... P2: RNK 9781405176255 BLUK110-Stouffer August 1, 2007 13:57 CHAPTER 1 Introduction to basic hemodynamic principles James E. Faber, George A. Stouffer Hemodynamics is concerned with the mechanical and physiologic properties controlling blood pressure and flow through the body. A full discussion of hemodynamic principles is beyond the scope of this book. In this chapter, we present an overview of basic principles that are helpful in understanding hemodynamics. 1. Energy in the blood stream exists in three interchangeable forms: pressure arising from cardiac output and vascular resistance, hydrostatic pressure from gravitational forces, and kinetic energy of blood flow Daniel Bernoulli was a physician and mathematician who lived in the eigh- teenth century. He had wide-ranging scientific interests and won the Grand Prize of the Paris Academy 10 times for advances in areas ranging from astron- omy to physics. One of his insights was that the energy of an ideal fluid (a hypothetical concept referring to a fluid that is not subject to viscous or fric- tional energy losses) in a straight tube can exist in three interchangeable forms: perpendicular pressure (force exerted on the walls of the tube perpendicular to flow; a form of potential energy), kinetic energy of the flowing fluid, and pressure due to gravitational forces. Perpendicular pressure is transferred to the blood by cardiac pump function and vascular elasticity and is a function of cardiac output and vascular resistance.
    [Show full text]
  • Physiologic Blood Flow Is Turbulent
    www.nature.com/scientificreports OPEN Physiologic blood fow is turbulent Khalid M. Saqr1*, Simon Tupin1, Sherif Rashad2,3, Toshiki Endo3, Kuniyasu Niizuma2,3,4, Teiji Tominaga3 & Makoto Ohta1 Contemporary paradigm of peripheral and intracranial vascular hemodynamics considers physiologic blood fow to be laminar. Transition to turbulence is considered as a driving factor for numerous diseases such as atherosclerosis, stenosis and aneurysm. Recently, turbulent fow patterns were detected in intracranial aneurysm at Reynolds number below 400 both in vitro and in silico. Blood fow is multiharmonic with considerable frequency spectra and its transition to turbulence cannot be characterized by the current transition theory of monoharmonic pulsatile fow. Thus, we decided to explore the origins of such long-standing assumption of physiologic blood fow laminarity. Here, we hypothesize that the inherited dynamics of blood fow in main arteries dictate the existence of turbulence in physiologic conditions. To illustrate our hypothesis, we have used methods and tools from chaos theory, hydrodynamic stability theory and fuid dynamics to explore the existence of turbulence in physiologic blood fow. Our investigation shows that blood fow, both as described by the Navier–Stokes equation and in vivo, exhibits three major characteristics of turbulence. Womersley’s exact solution of the Navier–Stokes equation has been used with the fow waveforms from HaeMod database, to ofer reproducible evidence for our fndings, as well as evidence from Doppler ultrasound measurements from healthy volunteers who are some of the authors. We evidently show that physiologic blood fow is: (1) sensitive to initial conditions, (2) in global hydrodynamic instability and (3) undergoes kinetic energy cascade of non-Kolmogorov type.
    [Show full text]